Traws Pharma
TRAW
TRAW
27 hedge funds and large institutions have $1.27M invested in Traws Pharma in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
42% less capital invested
Capital invested by funds: $2.19M → $1.27M (-$919K)
Holders
27
Holding in Top 10
–
Calls
$5K
Puts
–
Top Buyers
| 1 | +$22.2K | |
| 2 | +$16.9K | |
| 3 | +$7.78K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$160 |
| 5 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
+$87 |
Top Sellers
| 1 | -$36.4K | |
| 2 | -$34.5K | |
| 3 | -$23.5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.35K |
| 5 |
Millennium Management
New York
|
-$776 |